Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investorsProceeds support the ...

Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. As a ...

The Royce Smaller-Companies Growth Fund returned 19.3% in 2025, outperforming its benchmarks. Read the full analysis for more ...

Nominated KRRO-121 development candidate for the potential treatment of hyperammonemia in patients with urea cycle disorders and hepatic encephalopathyAdvanced GalNAc-conjugated oligonucleotide for ...

Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated ...

Colorectal cancer is increasing in younger patients and is now the leading cause of cancer death in those under age 50, yet ...

Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

Royce Smaller-Companies Growth Fund reports strong 2025 results led by Health Care and Industrials sectors. Read the full ...

CAMBRIDGE, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...

After just more than a month of long meetings, sharp disagreements and hard-fought compromises, the Oregon Legislature must ...